| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/02/1999 | US5866588 Dual histamine (h1) and platelet activating factor (paf) receptor antagonists. |
| 02/02/1999 | US5866577 Aromatic amidine derivatives and salts thereof |
| 02/02/1999 | US5866571 Treatment of inflammations, thromboembolic diseases and cardiovascular diseases. |
| 02/02/1999 | US5866542 Nematode-extracted anticoagulant protein |
| 02/02/1999 | US5866540 Cyclic adhesion inhibitors |
| 02/02/1999 | US5866373 Polynucleotide encoding a human chemotactic protein |
| 02/02/1999 | US5866122 Using prothrombinase |
| 02/02/1999 | CA2182200C Formulations for factor ix |
| 02/02/1999 | CA1340363C Mutant acidic fibroblast growth factor |
| 02/02/1999 | CA1340362C Thiadiazinones |
| 01/29/1999 | CA2243882A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 01/28/1999 | WO1999003992A1 Trail receptor |
| 01/28/1999 | WO1999003882A2 Human leukocyte calcium activated potassium channel polypeptide |
| 01/28/1999 | WO1999003854A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/28/1999 | WO1999003557A1 Blood processing systems and methods which optically derive the volume of platelets contained in a plasma constituent |
| 01/28/1999 | WO1999003484A1 Therapeutic hemoglobin composition having isotropically increased size |
| 01/28/1999 | WO1998046576A3 Halo-alkoxycarbonyl prodrugs |
| 01/28/1999 | CA2296700A1 Therapeutic hemoglobin composition having isotropically increased size |
| 01/28/1999 | CA2295719A1 Trail receptor |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0892849A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892786A1 New carboxylic acid derivatives, their production and use |
| 01/27/1999 | EP0892783A1 Carboxylic acid derivatives with an aggregation-inhibiting action |
| 01/27/1999 | EP0765339B1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors |
| 01/27/1999 | CN1041799C Preparation of thrombolytic composition |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5864009 Including at least one nematode-extracted anticoagulant protein domain (?nap domain?), wherein said nap domain has an amino acid sequence having a molecular weight of about 8.7 to 8.8 kilodaltons, and contains ten cysteine amino acid residues |
| 01/26/1999 | US5863929 Anticoagulant agents |
| 01/26/1999 | US5863918 Naphthalene derivatives |
| 01/26/1999 | US5863914 Administering to human n,n-dimethylbenzene or n,n-dimethylnaphthalene-cyclic urea derivative to treat a disease-state caused by inhibition of factor xa |
| 01/26/1999 | US5863893 Anticoagulants |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA2059865C Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/21/1999 | WO1999002710A1 Production and use of recombinant protein multimers with altered biological activity |
| 01/21/1999 | WO1999002565A2 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | WO1999002564A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | WO1999002551A1 Integrin binding peptide and use thereof |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002542A1 New formulation |
| 01/21/1999 | WO1999002171A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2332636A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2296071A1 Production and use of recombinant protein multimers with altered biological activity |
| 01/21/1999 | CA2295688A1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | CA2295474A1 123 human secreted proteins |
| 01/21/1999 | CA2295218A1 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891359A1 Novel oxazolidine derivatives, process for their production and medicaments containing them |
| 01/20/1999 | EP0855913A4 Iron dextran formulations |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0668877B1 Displacement chromatography process and purified hemoglobin product |
| 01/20/1999 | EP0642352B1 TRUNCATED TISSUE FACTOR AND FVIIa OR FVII ACTIVATOR FOR BLOOD COAGULATION |
| 01/20/1999 | EP0641327B1 Novel alpha-mannosidase inhibitors |
| 01/20/1999 | CN1205205A Pyrazolopyridine compound and processes for preparation thereof |
| 01/20/1999 | CN1041730C Method for preparing tetrahydrothienopyridine derivatives |
| 01/19/1999 | US5861488 Gene therapy and gene expression of antisickling globulin proteins |
| 01/19/1999 | US5861426 Nitro esters of aromatic compounds with amide or ester groups |
| 01/19/1999 | US5861414 Inhibiting blood platelet aggregation for antithrombotic disorders |
| 01/19/1999 | US5861404 2,9-disubstituted purin-6-ones |
| 01/19/1999 | US5861393 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 01/19/1999 | US5861377 Antistasin type serine protease inhibitors |
| 01/19/1999 | US5861170 Acetylsalicyclic acid-containing transdermal application system for antithrombotic therapy |
| 01/19/1999 | CA2081703C Thrombin and method of producing the same |
| 01/19/1999 | CA2025900C Derivative of tissue-type plasminogen activator |
| 01/19/1999 | CA2003326C Bone marrow suppressing agents |
| 01/14/1999 | WO1999001472A1 Cyclic azapeptides with angiogenic effect |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | WO1999001146A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds |
| 01/14/1999 | DE19729544A1 Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung Ancrod specific monoclonal antibodies, antibody fragments, their mixture or their derivatives and the use thereof |
| 01/14/1999 | CA2297181A1 Cyclic azapeptides |
| 01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2264792A1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 01/13/1999 | EP0890640A2 G-CSF analog compositions and methods |
| 01/13/1999 | EP0889726A1 Novel cycloalkyl substituted imidazoles |
| 01/13/1999 | EP0555327B1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
| 01/12/1999 | US5859271 Inhibitors of phospholipase that prevent phospholipase mediated injury, injury due to oxidation, and inflammation; side effect reduction |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859244 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/12/1999 | US5859204 Non-antigenic, non-immunogenic superior coagulant human/porcine hybrid by site directed mutagenesis; hemophilia |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859041 Substituted imidazoles having cytokine inhibitory activity |
| 01/12/1999 | US5859005 Inhibitors of thrombin and factor xa |
| 01/12/1999 | US5858979 Anticoagulant peptides |
| 01/12/1999 | US5858972 Cyclic peptide |
| 01/12/1999 | US5858969 Administering to treat adult respiratory distress syndrome |
| 01/12/1999 | US5858643 Red blood cell composition containing vitamin E or derivatives thereof which exhibits reduced potassium ion leakage after a photoinactivation process |
| 01/12/1999 | US5858347 Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors |
| 01/12/1999 | CA2153896C G-csf analog compositions and methods |
| 01/07/1999 | WO1999000500A1 Calcium-binding phosphoprotein |